[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"aecopd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:aecopd":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":4},"100632134","effect-of-pulmonary-rehabilitation-in-females-with-acute-exacerbation-of-copd-induced-by-biomass-fuel-smoke-100632134",false,"NCT07509736","Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke","Effect of Pulmonary Rehabilitation in Females With Acute Exacerbation of COPD Induced by Biomass Fuel Smoke Randomized Controlled Trial","AECOPD BIOMASS","Inclusion Criteria:\n\n* Only females diagnosed with a history of using biomass fuel for cooking and heating during their lifetime with no history of smoking or being Ex smoker nor a non-smoker.\n* Participants in clear consciousness.\n* participants diagnosed with shortness of breath or dyspnea that was not caused by heart disease, pneumothorax, or pulmonary oedema\n\nExclusion Criteria:\n\n* Systolic blood pressure lower than 90 mmHg.\n* Participants with unstable psychological status, hemoptysis, pneumothorax, pulmonary edema.","FEMALE","50 Years",{"count":20,"type":21},60,"ESTIMATED","INTERVENTIONAL",[24],"NA","COPD represents an important public health challenge that is both preventable and treatable. GOLD is committed to improving the health of people at risk of and with COPD, wherever they happen to have been born, and wishes to do its bit to help achieve the United Nations Sustainable Development Goal to reduce premature mortality from non-communicable diseases - including COPD - by one third by 2030. GOLD aims in stable COPD to relieve symptoms, improve exercise tolerance and improve health status. Non-pharmacological interventions for those high-risk groups of patients, studies of intervention strategies both during inpatient stay and shortly after discharge have been undertaken, to decrease readmission rates and improve QOL, including disease-specific self-management, pulmonary rehabilitation, and early medical follow-up.Seeking for allow cost way to alleviate patients' symptoms in order to increase independence and QOL.",[27,28,29],"AECOPD","BIOMASS FUEL","Pulmonary Rehabilitation",[31],"AECOPD-Anexity-depression-Biomass fuel","NOT_YET_RECRUITING","2026-03-29",{"date":35,"type":36},"2026-04-03","ACTUAL",{"date":38,"type":21},"2026-03-20",{"date":40,"type":21},"2026-06-20",{"name":42,"class":43},"Beni-Suef University","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":50,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":52,"minAge":4,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":57,"conditions":58,"keywords":63,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":80},"100587544","phase-4-do-blood-tests-help-to-decide-which-patients-with-flares-of-chronic-obstructive-pulmonary-disease-copd-need-antibiotics-and-steroids-100587544","NCT06929767","Do Blood Tests Help to Decide Which Patients With Flares of Chronic Obstructive Pulmonary Disease (COPD) Need Antibiotics and Steroids?","Biomarker Guided Decision-making in Acute Exacerbation of COPD: a Feasibility Study","Bidex","Inclusion Criteria:\n\n* Outpatients with a known diagnosis of COPD (must have prior spirometry documenting FEV1\u002FFVC post-bronchodilator \\\u003C 0.7 or documented respirologist-diagnosis of COPD)\n* Presenting with AECOPD, defined as an increase in respiratory symptoms necessitating an increase in medications\n* Consent provided\n\nExclusion Criteria:\n\n* An individual who meets any of the following criteria will be excluded from participation in this study:\n* new infiltrate on chest x-ray day of randomization\n* temperature ≥ 38.0 ◦C taken orally day of randomization\n* positive blood culture day of randomization\n* co-morbid asthma or severe bronchiectasis\n* acute heart failure day of randomization\n* known immunosuppression including the use of chronic glucocorticoids day of randomization\n* allergy\u002Fabsolute contraindication to the use of oral steroids\n* planned pregnancy or currently pregnant\n* COVID positive","ALL",{"count":54,"type":21},80,[56],"PHASE4","The goal of this clinical trial is to see if the use of two simple blood tests: C reactive protein and eosinophils, can reduce the use of steroids and antibiotics in patients with flares of chronic obstructive pulmonary disease (COPD) without reducing the chance of treatment success. Before we undertake a large trial to answer these questions, we need to do a small feasibility study to see if our study design will work. The questions we need to answer include:\n\nHow many participants will we able to include in the study over 12 months?\n\nHow many participants in the trial will take all of their medications?\n\nWill study protocols be followed?\n\nHow much information will we be missing at the end of the study?\n\nHow many study participants will take photographs of the phlegm they are coughing up or bring in a sample of the phlegm for inspection by study doctor?\n\nParticipants will:\n\nCome into the clinic to be assessed when they have a flare of COPD, get a chest x-ray, blood work, and a doctor visit. The doctor will provide a prescription if it is a flare of COPD.\n\nThe participant will get a call 3, 14, and 30 days later by a study researcher to ask questions about if the medications have been taken, if cough or shortness of breath remain, and if they have had to seek additional care from another doctor, clinic, or emergency room.",[59,60,61,27,62],"Chronic Obstructive Pulmonary Disease","COPD","Exacerbation of COPD","ECOPD",[64,65,66,67,68,69,27,70],"bio-maker","C reactive protein","CRP","eosinophils","exacerbation","COPD exacerbation","biomarker","2025-04-08",{"date":73,"type":36},"2025-04-16",{"date":75,"type":21},"2025-09-01",{"date":77,"type":21},"2026-10-01",{"name":79,"class":43},"Ottawa Hospital Research Institute",1]